Sivik Global Healthcare’s Danaher DHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.79M Hold
20,000
2.88% 14
2026
Q1
$3.79M Sell
20,000
-3,000
-13% -$639K 2.88% 14
2025
Q4
$5.26M Sell
23,000
-12,000
-34% -$2.64M 1.53% 22
2025
Q3
$6.94M Sell
35,000
-5,000
-13% -$995K 2.02% 14
2025
Q2
$7.9M Buy
40,000
+5,000
+14% +$970K 2.15% 16
2025
Q1
$7.17M Buy
35,000
+10,000
+40% +$2.18M 3.88% 7
2024
Q4
$5.74M Sell
25,000
-5,000
-17% -$1.23M 3.02% 13
2024
Q3
$8.34M Hold
30,000
3.53% 10
2024
Q2
$7.5M Hold
30,000
2.69% 12
2024
Q1
$7.49M Buy
30,000
+5,000
+20% +$1.22M 1.76% 11
2023
Q4
$5.78M Sell
25,000
-6,020
-19% -$1.28M 2.42% 21
2023
Q3
$6.82M Buy
31,020
+2,820
+10% +$629K 3.45% 13
2023
Q2
$6M Buy
28,200
+5,640
+25% +$1.19M 1.4% 24
2023
Q1
$5.04M Hold
22,560
2.17% 24
2022
Q4
$5.31M Sell
22,560
-5,640
-20% -$1.31M 2.5% 20
2022
Q3
$6.46M Sell
28,200
-1,128
-4% -$276K 3.59% 6
2022
Q2
$6.59M Sell
29,328
-1,692
-5% -$390K 3.75% 9
2022
Q1
$8.07M Buy
31,020
+2,820
+10% +$706K 3.33% 4
2021
Q4
$8.22M Sell
28,200
-5,640
-17% -$1.55M 3.52% 5
2021
Q3
$9.13M Hold
33,840
2.18% 12
2021
Q2
$8.05M Sell
33,840
-8,460
-20% -$1.88M 1.57% 17
2021
Q1
$8.44M Sell
42,300
-2,820
-6% -$573K 3.08% 9
2020
Q4
$8.89M Sell
45,120
-5,640
-11% -$1.13M 3.62% 8
2020
Q3
$9.69M Sell
50,760
-39,480
-44% -$7.02M 4.17% 2
2020
Q2
$8.06M Sell
90,240
-39,480
-30% -$5.67M 2.67% 16
2020
Q1
$10.2M Buy
129,720
+73,320
+130% +$9.88M 4.02% 6
2019
Q4
$7.67M Buy
56,400
+5,640
+11% +$713K 2.85% 11
2019
Q3
$6.5M Sell
50,760
-5,640
-10% -$706K 3.28% 9
2019
Q2
$7.15M Sell
56,400
-11,280
-17% -$1.34M 1.73% 6
2019
Q1
$7.92M Buy
67,680
+16,920
+33% +$1.73M 2.92% 7
2018
Q4
$4.64M Buy
+50,760
New +$4.61M 2.5% 18
2017
Q4
Sell
-62,040
Closed -$4.72M 73
2017
Q3
$4.72M Buy
+62,040
New +$4.59M 1.61% 25

Other funds holding DHR

Sivik Global Healthcare's DHR Position: Q2 2026 in Review

Sivik Global Healthcare held its Danaher (DHR) position steady in Q2 2026 at 20,000 shares worth $3.79M. The position accounts for 2.88% of the portfolio, ranked #14.

Sivik Global Healthcare first reported a position in DHR in Q3 2017 and has held it in 32 quarters since. The position peaked at $10.2M in Q1 2020. 607 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • Sivik Global Healthcare held 20,000 shares of Danaher worth $3.79M as of Q2 2026.
  • Sivik Global Healthcare left its Danaher share count unchanged in Q2 2026.
  • Danaher made up 2.88% of Sivik Global Healthcare's portfolio in Q2 2026, its #14 holding.
  • Sivik Global Healthcare first reported a position in Danaher in Q3 2017 and has held it in 32 quarters since.
  • Sivik Global Healthcare's Danaher position peaked at $10.2M in Q1 2020.
  • 607 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.